Observational analysis reveals delivery device challenges in self-administering LVSC for primary immunodeficiency, indicating user needs.
Key Points
Participants reported significant challenges with the self-administration of SCIg, including device setup and maintenance issues.
The study gathered qualitative data through video recordings and open responses from 11 patients diagnosed with PIDD, highlighting real-world experiences.
Emerging themes emphasized a strong preference for subcutaneous administration but detailed various pain points affecting user experience.
Insights from patient experiences help identify necessary improvements for LVSC delivery devices and inform future development efforts.